Key facts
- Mary DiBiase has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $518,005.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Mary DiBiase
- Location
- Boston, MA
- Summary
- The estimated net worth of Mary DiBiase is at least $518,005 dollars as of 14 Feb 2025. Mary DiBiase is the Chief Operating Officer of X4 Pharmaceuticals, Inc and owns shares of X4 Pharmaceuticals, Inc (XFOR) stock worth about $518K.
- Signature
- /s/ Adam S. Mostafa, attorney-in-fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Mary DiBiase and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Change
- Largest disclosed position: X4 Pharmaceuticals, Inc ($518,005).
- Past-year value change for that position: .
Research use
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Mary DiBiase
XFOR
Forms 3/4/5
X4 Pharmaceuticals, Inc
- Relationship
- Chief Operating Officer
- Holdings value
- $518,005
- Past year net change
- Change %
- Report period
- 12 Feb 2025
Insider Transactions Reported by Mary DiBiase:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.